Cited by 3Ubiquitin and proteasome pathwaysAlzheimer's disease research and treatmentsGenetic Neurodegenerative Diseases

Chapter 7 Ubiquitinopathies

Dickson, Dennis W.·2007·Blue Books of Neurology

Integrity signals

Registry

Crossref · 10.1016/s1877-184x(09)70058-9

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In neurological disease and aging, modified proteins are the histopathological hallmarks of a number of diseases, such as SOD1 in amyotrophic lateral sclerosis (ALS), and a class of diseases long referred to as the proteinopathies, including tauopathies in Alzheimer's disease and inclusions of amyloid beta, alpha-synuclein in Parkinson's and multiple secondary ubiquitinopathies.

    “In neurological disease and aging, modified proteins are the histopathological hallmarks of a number of diseases, such as SOD1 in amyotrophic lateral sclerosis (ALS) 56,57 , and a class of diseases long referred to as the proteinopathies 57 , including tauopathies in Alzheimer's disease 58 and inclusions of amyloidβ 59 , α -synuclein in Parkinson's 60,61 and multiple secondary ubiquitinopathies”

    From How many human proteoforms are there? (2018) · cites this paper as [62]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dickson, D. W.
Corresponding author
Dickson, Dennis W.
Venue
Blue Books of Neurology
Publisher
Elsevier
Published
2007
Pages
165-185
ISSN
  • 1877-1831 (ISSN-L)
  • 1877-184X
OpenAlex
W1498802183
Cited by
3
References
5
Citations by year
2020: 1 · 2018: 1 · 2017: 1
FWCI
0.00
Type
book chapter
Language
en
Open access
closed
Locations
Blue books of neurology (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
neurodegeneration, frontotemporal lobar degeneration, motor neuron disease, amyotrophic lateral sclerosis, Alzheimer's disease, protein aggregation, inclusion bodies, ubiquitin conjugation, aging, neurofibrillary tangles, Bunina bodies, granulovacuolar degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review